Abstract:Kaposi's sarcoma associated herpesvirus (KSHV) has gained considerable attention as a type of carcinogenic pathogen. Recent research suggests that KSHV has participated in the pathogenesis of Kaposi's sarcoma-related malignant neoplastic diseases. Viral lytic infection might be pivotal for the etiopathogenesis of KSHV-induced diseases; however, most clinical KSHV lytic replication inhibitors like ganciclovir, nelfinavir, or cidofovir do not restrain virus replication effectively enough to achieve clinical efficacy. In our continued pharmaceutical studies on Chinese herbal medicines, new acylphloroglucinol-based meroterpenoid enantiomers have been discovered from Hypericum japonicum. Most of these metabolites have potential inhibitory activities that target KSHV lytic replication. Amongst these analogues, compounds 1a and 1b possess an unreported ring system cyclopenta[b]chromene. Compounds 1a with 4a exhibit stronger inhibitory activities towards the lytic replication of KSHV in Vero cells. In addition, 1a and 4a have IC50 values of 8.30 and 4.90 μM and selectivity indexes of 23.49 and 25.70, respectively. Qualitative and quantitative SAR and molecular docking studies for acylphloroglucinol-based meroterpenoids with regard to anti-KSHV activity were conducted. An explanation for the variation in the activity and selectivity indexes was proposed in accordance with the predicted binding pose found with molecular docking to a putative target, thymidylate synthase (kTS). Compounds 1a and 4a have potential for further development and optimization of their anti-KSHV activities which could lead to new candidate drugs.

(+/-)-Japonicols A-D, Acylphloroglucinol-Based Meroterpenoid Enantiomers With Anti-Kshv Activities From Hypericum Japonicum

(±)-Japonones A and B, Two Pairs of New Enantiomers with Anti-Kshv Activities from Hypericum Japonicum.

Discovery of Acylphloroglucinol-Based Meroterpenoid Enantiomers As KSHV Inhibitors from Hypericum Japonicum

Enantiomeric pairs of meroterpenoids with 11/5/6 spiro-heterocyclic systems from Hypericum kouytchense

Two New Bioactive Α-Pyrones from Hypericum Japonicum

(±)-Hypermonanones A-G, Seven Pairs of Monoterpenoid Polyprenylated Acylphloroglucinol Enantiomers from Hypericum Monanthemum

A New Phloroglucinol Diglycoside Derivative from Hypericum Japonicum Thunb.

Hyjapones A-D, trimethylated acyphloroglucinol meroterpenoids from Hypericum japonicum thunb. With anti-inflammatory activity

Discovery of New Filicinic Acid-based Meroterpenoids from Hypericum Japonicum

Kiiacylphnols A−H, eight undescribed polycyclic polyprenylated acylphloroglucinols with anticancer activities from Hypericum przewalskii Maxim

Acylphloroglucinols-based Meroterpenoid Enantiomers with Antiviral Activities from Dryopteris Crassirhizoma

Hyperascyrones A–H, Polyprenylated Spirocyclic Acylphloroglucinol Derivatives from Hypericum Ascyron Linn.

Monoterpenoid Acylphloroglucinols from Hypericum Hengshanense W. T. Wang with Antiproliferative Activities

Cytotoxic phenolic constituents from Hypericum japonicum.

Polyisoprenylated Benzoylphloroglucinol Derivatives from Hypericum Scabrum

(±)-Hypandrone A, a Pair of Polycyclic Polyprenylated Acylphloroglucinol Enantiomers with a Caged 7/6/5/6/6 Pentacyclic Skeleton from Hypericum Androsaemum

Polycyclic Polyprenylated Acylphloroglucinols with Immunosuppressive Activity from Hypericum Perforatum and Absolute Configurations Assignment of Previously Reported Analogues.

Hypermongones A-J, Rare Methylated Polycyclic Polyprenylated Acylphloroglucinols from the Flowers of Hypericum Monogynum.

Hyperisampsins N and O, Two New Benzoylated Phloroglucinol Derivatives from Hypericum Sampsonii

(±)-Walskiiglucinol A, a Pair of Rearranged Acylphloroglucinol Derivative Enantiomers from Hypericum Przewalskii.

Hyperxylones A and B, Two Polycyclic Polyprenylated Acylphloroglucinols with a Benzoyl Substituted Bicyclo[3.2.1]octane Core from Hypericum Beanii